The Innovator Awards recognize UCI researchers working to move UCI knowledge and discoveries to market

UC Irvine Beall Applied Innovation, with generous support from Don and Ken Beall, created the annual Innovator Awards to recognize UC Irvine researchers working actively to promote commercialization of university intellectual property, which supports industry growth and moves inventions from the lab to market to benefit humankind.

Early Career Innovator/Emerging Innovation of the Year:

Recognizes distinguished innovators who have demonstrated excellence in the early stage of their careers, or in the early stages of an innovation breakthrough, through a combined effort in outstanding research and innovation.

This Year’s Awardees:

EMERGING INNOVATION/EARLY CAREER INNOVATOR OF THE YEAR

Liangzhong (Shawn) Xiang, Ph.D.
Professor, Radiological Sciences
UC Irvine School of Medicine
Professor, Biomedical Engineering
UC Irvine Samueli School of Engineering

Click here to learn more on the UC Irvine Beall Applied Innovation website.

Bruce J. Tromberg, PhD, to Deliver School of Medicine’s Commencement Address

UC Irvine School of Medicine will celebrate its Class of 2026 MDs, residents, and fellows at commencement on Saturday, May 16, at 2 p.m. in the Bren Events Center. This is a ticketed event; anyone unable to attend in person can view the ceremony through the livestream link.

This year’s featured commencement speaker is Bruce J. Tromberg, PhD, director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health, where he leads programs advancing engineering, physical science and computational technologies in biology and medicine. He also spearheaded the NIH’s Rapid Acceleration of Diagnostics (RADx Tech) initiative to expand COVID-19 testing and accelerate the development of innovative diagnostic and point-of-care technologies. His research focuses on optical and photonic technologies for biomedical imaging and therapy, including portable and wearable tools for real-time, noninvasive monitoring of tissue health.

Prior to joining NIH in 2019, Tromberg spent nearly three decades at UC Irvine, where he was a professor of surgery and biomedical engineering, director of the Beckman Laser Institute and Medical Clinic, and a co-founder of the Department of Biomedical Engineering. An internationally recognized leader in biophotonics, he has authored more than 450 publications, holds numerous patents, and has trained more than 100 students and fellows. He is also co-founder of the biophotonics company Modulim Inc., a member of the National Academies of Medicine and Engineering, and a fellow of multiple leading scientific organizations.

We look forward to welcoming Tromberg and celebrating the School of Medicine Class of 2026!

Click here to read the full UC Irvine School of Medicine announcement.

BERNARD CHOI NAMED DIRECTOR OF UC IRVINE BECKMAN LASER INSTITUTE & MEDICAL CLINIC

Biomedical Optical Imaging Scientist to Lead Premier Laser Research Institute

UC Irvine has appointed Dr. Bernard Choi as Director of Beckman Laser Institute & Medical Clinic, following a comprehensive national search. The appointment marks a new chapter for one of the world’s leading centers for biomedical photonics, laser medicine, and translational optical research.

A long-standing member of the UC Irvine research community, Dr. Choi has served as the Institute’s Interim Director for the past three years, guiding the team through a period of significant growth and scientific achievement. As Professor of Biomedical Engineering and Surgery, he bridges the School of Medicine and the Henry Samueli School of Engineering. His service as Associate Chair of Undergraduate Studies in Biomedical Engineering further reflects a deep and abiding dedication to the university’s educational mission.

“The next chapter of the Institute is about translation, moving new innovations in optical and photonic technologies out of the laboratory and impacting patient care,” said Dr. Choi. “That vision only succeeds if we are equally committed to the educators and trainees who will carry this field forward.”

Dr. Choi earned his B.S. in Biomedical Engineering from Northwestern University. He went on to complete both his M.S.E. and Ph.D. in Biomedical Engineering from the University of Texas at Austin.

At the core of Dr. Choi’s scientific mission is the development of in vivo optical imaging methods for monitoring biological tissues in both normal and diseased states. Dr. Choi’s group is internationally recognized for advancing laser speckle imaging (LSI) to monitor blood flow in real time, alongside complementary modalities such as spatial frequency domain imaging (SFDI). These techniques have been applied to intrasurgical monitoring, burn triage, hemorrhage monitoring, wound healing assessment, and cerebral blood flow measurement, establishing the Institute as a leader in translational biophotonics. His laboratory is world-renowned for pioneering work in optical clearing (the use of chemical agents to reduce the scattering properties of biological tissue). This technique enables high-resolution, three-dimensional optical imaging and opens new frontiers in understanding disease progression and response to novel therapies.

To date, Dr. Choi has authored 157 peer-reviewed publications and holds seven patents. He has secured competitive extramural funding from the National Institutes of Health (NIH), the National Science Foundation (NSF), the Department of Defense (DoD), the Defense Advanced Research Projects Agency (DARPA), and other federal sponsors.

Dr. Choi’s active research portfolio reflects a consistent ability to move optical science from the benchtop to the bedside. With NIH support, he is developing a wearable optical patch to continuously monitor tissue perfusion, blood oxygenation, and microvascular function in real time with broad implications for remote patient care and personalized medicine. Supported by the National Heart, Lung, and Blood Institute (NHLBI), Dr. Choi is also developing an optical monitoring device to improve real-time assessment of maternal and fetal health during pregnancy and childbirth, addressing a critical gap in modern medicine. This work extends to field-deployable applications in military medicine, emergency response, and pre-hospital care.

Dr. Choi is equally invested in education and workforce development. He is establishing a UC Irvine Core Optical Laboratory Resource (COLR), a hands-on training facility for scientists, engineers, and clinicians in fundamental and applied optics and photonics. As co-PI of the Access to Careers in Engineering and Sciences (ACES) program, he leads an eight-week summer initiative providing undergraduate students from Historically Black Colleges and Universities (HBCUs) with immersive research experiences and mentorship in biomedical engineering and optical medicine. He also co-directs the NIH-funded Innovative Programs to Enhance Research Training (IPERT) program and serves as co-Principal Investigator (co-PI) on the NSF Team Science for Integrated Biomedical Engineering and Social Science Training (BEST) graduate training program. As PI of the Air Force Office of Scientific Research (AFOSR)-funded Military Medical Photonics center at the Institute, he collaborates with researchers in translating optical science to military medicine.

As Director, Dr. Choi will oversee the Institute’s research portfolio, operations, educational programs, and strategic direction. He assumes leadership of an institution with a distinguished history of scientific excellence, interdisciplinary collaboration, and real-world clinical impact.

“For nearly four decades, the Institute has transformed the way light is used to understand, diagnose, and heal,” said Dr. Choi. “My priorities now are clear: accelerate the translation of optical science into patient care, strengthen biophotonics education at every level, and cultivate a strong network of supporters to sustain our life-changing work for decades to come.”

 

 

 

 

Lifestyle, dietary habits can contribute to early hair loss

Researchers learned about condition, how body responds to inflammation during COVID-19 pandemic, says UCI Health dermatologist

IN THE NEWS: The exact causes of hair loss are not fully known, but some researchers say lifestyle and dietary habits can bring on early onset of genetic hair loss. UCI Health board certified dermatologist Dr. Natasha Mesinkovska spoke with MarketWatch about some of the reasons people experience it.

“We learned a lot about hair loss through the pandemic, and then it highlighted how our body responds to inflammation.”

COVID-19 can also cause temporary hair shedding during and after infection.

Mesinkovska also says GLP-1s can trigger temporary hair loss due to rapid weight loss in people who don’t eat very much or very well while taking the medicines. In some cases, she encourages patients to slow down their weight loss by staying on a lower dose of the medicines.

Mesinkovska is a board-certified UCI Health dermatologist who specializes in the diagnosis and treatment of skin disorders, including skin cancer. Her research interests include alopecia and dermatitis and she is the author or co-author of many articles in peer-reviewed publications.

In addition, she is an investigator on several current clinical trials involving alopecia, atopic dermatitis, psoriasis and skin laxity. She is also an associate professor of dermatology and the vice chair for clinical research in the Department of Dermatology at UC Irvine School of Medicine. Mesinkovska also serves as the director of integrative dermatology at the Beckman Laser Institute and the chief scientific officer of the National Alopecia Areata Foundation.

About UCI Health

UCI Health, one of California’s largest academic health systems, is the clinical enterprise of the University of California, Irvine. The 1,461-bed system comprises its main campus UCI Health — Orange, its flagship hospital, the UCI Health — Irvine acute care hospital and medical campus, four hospitals and affiliated physicians of the UCI Health Community Network in Orange and Los Angeles counties and a network of ambulatory care centers across the region. UCI Health — Orange provides tertiary and quaternary care and is home to the only Orange County-based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. Powered by UC Irvine, UCI Health serves 5.6 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us on FacebookInstagramLinkedIn and X (formerly Twitter).

Click here or visit https://www.ucihealth.org/about-us/news/2026/04/hair-loss to full UCI Health news article.

A MESSAGE FROM VICE CHANCELLOR FOR RESEARCH AILEEN ANDERSON

Directorship of the Beckman Laser Institute & Medical Clinic (BLIMC)

I am pleased to announce the appointment of Professor Bernard Choi as the next director of the Beckman Laser Institute and Medical Clinic (BLIMC), a Special Research Program (SRP).

Professor Choi, a long-time member and researcher at BLIMC, has served as its Interim Director for the past 3 years. He holds joint appointments in the Departments of Surgery and Biomedical Engineering. He received his B.Sc. from Northwestern University, and his M.S.E. and Ph.D. in Biomedical Engineering from the University of Texas at Austin. Professor Choi’s research interests include the development and application of in vivo optical imaging methods and technologies for monitoring of biological tissues in normal and diseased states, and for novel therapy discovery. He also leads research efforts on the use of chemical agents to reduce the optical scattering of biological tissue.

The selection of Professor Choi as BLIMC director is the result of a national search. I wish to thank the committee members for their thoughtful consideration of the candidates, as well as the unique characteristics and needs of a major institute such as BLIMC. I eagerly await its next chapter. Please join me in congratulating Professor Choi on his new role.

Aileen Anderson, Ph.D.
Vice Chancellor for Research